{"schema_version":"secwatch.filing_event.v1","accession":"0001495320-24-000087","form_type":"8-K","ticker":"VRA","cik":"0001495320","company_name":"Vera Bradley, Inc.","filed_at":"2024-12-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.584417+00:00","generated_at":"2026-05-29T04:42:02.440946+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Vera Bradley Q3 revenues fall 30% to $80.6M; net loss $12.8M; guides FY25 revs ~$385M","bullets":["Consolidated net revenues of $80.6M down 30% YoY from $115.0M; net loss $12.8M vs prior year net income $5.1M.","Pura Vida segment revenues fell 42.9% YoY to $10.1M; Vera Bradley Direct comp sales down 27.2%.","FY2025 guidance: net revenues ~$385M (vs $470.8M FY2024), operating loss ~$9M, diluted EPS ~($0.25).","Company has no debt, $13.7M cash; $75M ABL facility undrawn; inventory $131.3M.","Board approved additional $30M share repurchase authorization; $4.4M remaining under current program."],"urls":{"canonical":"https://secwatch.observer/filing/0001495320-24-000087","json":"https://secwatch.observer/filing/0001495320-24-000087.json","markdown":"https://secwatch.observer/filing/0001495320-24-000087.md","text":"https://secwatch.observer/filing/0001495320-24-000087.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1495320/000149532024000087/0001495320-24-000087-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1495320/000149532024000087/vra-20241211.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T04:42:02.440946+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}